Partillion Bioscience Corporation
Publicly observedLos Angeles, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Los Angeles | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Partillion Bioscience Corporation | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | WMNNPP5BWQM5 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Sept 2026Publicly observed
NIH SBIR/STTR award: Nanovial Kits for Large-Scale Cell-Cell Interaction Sequencing
USD 979,071.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant16 Jul 2026Publicly observed
NIH SBIR/STTR award: Multiplexed analysis of antibody secreting cells for enhanced function first antibody discovery
USD 306,865.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant1 Apr 2025Publicly observed
NIH SBIR/STTR award: Scaling function-first antibody discovery leveraging memory B cells
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant1 Apr 2025Publicly observed
NIH SBIR/STTR award: Scaling function-first antibody discovery leveraging memory B cells
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.